Manish Modi PharmEasy Case Study
Manish Modi PharmEasy Case Study
Product Management
Certification Program
Assignment: Competitor
Analysis
Industry: Online
Medicine
2
Hello!
I am Manish Modi
I am here because I love to build products.
You can find me at [email protected]
3
1.
MAJOY PLAYERS LIST Let’s start
4
List of major players in the online medicine
space
COMPANY NAME
1. 1 MG
2. Net meds
3. MedLife
4. mCHEMIST
5. BookMeds
5
2.
INTRODUCTION PharmEasy
6
PharmEasy is one of the largest
pharmacy aggregators in India.
Which help patients connect
7
3.
COMPETITORS Direct and In-Direct
8
List of Direct and In-Direct Competitors
Direct In-Direct
1MG Apollo
NetMeds Care Pharma
MedLife GenMart
9
4 .Company Comparisions
10
Goals
PharmEasy DC1
Our goal at PharmEasy is to Our goal at DC1 is to make
make quality and affordable healthcare Understandable,
healthcare accessible to Accessible and Affordable
one and all
11
Mission
PharmEasy DC1
Helps and connect patients create a platform that
with local pharmacy stores stood for transparent,
and diagnostic centers authentic and accessible
across India. information for all
12
Strategies
PharmEasy DC1
▣ Pharmeasy is into hyper local The company used its app to
delivery of medicines . To help spread information on medicines.
you understand it is like They are using push notifications
Grofers for medicine. and emails to expand and let
▣ The customers are segmented people know that they are live in
based on the pin codes they their city. The company also uses
are staying and are matched offline advertisements depending
to the corresponding medical on the city. They use newspaper
stores in that area . advertisement and health camps
to spread information. But a
▣ The customer can order majority of their marketing is
through the app and get a digital.
cool discount of 20% or more 13
Current Number of Employees
872 Employees
PharmEasy
773 Employees
DC1
14
Revenue
PharmEasy DC1
▣ PharmEasy’s trading entity, ▣ DC1 sales grew by 72% to Rs
run by Thea Technologies Pvt. 268.1 crore in FY20 from Rs
Ltd, earned Rs 637 crore in 156.2 crore in FY19.
FY20 - compared to Rs 340
crore in FY19
15
PharmEasy Founder Profile
16
DC1 Founder Profile
17
Acquisitions
PharmEasy DC1
▣ PharmEasy has ▣ DC1 has acquired Dawailelo
acquired Medlife on Aug 18, on Sep 01, 2017 with an un-
2020. They discloser amount
acquired Medlife for $1.2B.
▣ DC1 has also acquired
MediAngles on Dec 14, 2016
with an un-discloser amount
18
Target Market
PharmEasy
▣ The Target market are the general customer, retail pharmacies & certified
diagnostic labs
SERVICES
Diagnostic Test
Healthcare Products
Order Medicines
19
TAM (Total Addressable Market)
▣ The e-pharma market is expected to grow at a fast pace in India given the
tailwinds that the industry is witnessing. The total addressable e-pharma
market value stood at around 360 million U.S. dollars in 2019.
20
SAM (Serviceable Available Market)
▣ It is possible to target the tier-1 & 2 Cities of India because the target audience is
more.
Example:- Delhi , Mumbai , Kolkata, Chennai ETC…
▣ In SOM we will be targeting the user who are educated to use smart phone and
person who will be required medicine as per the daily basis.
21
5.
COMPARATIVE
ANALYSIS PharmEasy VS DC1
22
PharmEasy Business Model
BUSINESS MODEL EXAMPLES PROS RISK
MARKET PLACE Paytm , Amazon 1. Can target large 1.Low Margin
,FlipKart customer 2. Unaware about the
2. Maintenance Cost customer segment
details
BIG BRANDS 1mg , Medlife 1. Strong Brand Pull 1.Brand power
2. Ride on with the dilution
marketing efforts of 2. High inventory
the brands Risk
PRIVATE LABLES Himalya , Apollo , Cipa 1. High Margin NA
2. More Supply
OFFLINE DISTRIBUTION The local medical 1. Fixed Customer Inventory Risk
CHANNEL FOR LONG TAIL shops and the False Information
PRODUCTS
distributers
23
PharmEasy Business Model
24
DC1 Business Model
BUSINESS MODEL EXAMPLES PROS RISK
MARKET PLACE Paytm , Amazon 1. Can target large 1.Low Margin
,FlipKart customer 2. Unaware about the
2. Maintenance Cost customer segment
details
BIG BRANDS 1mg , Medlife 1. Strong Brand Pull 1.Brand power
2. Ride on with the dilution
marketing efforts of 2. High inventory
the brands Risk
PRIVATE LABLES Himalya , Apollo , Cipa 1. High Margin NA
2. More Supply
OFFLINE DISTRIBUTION The local medical 1. Fixed Customer Inventory Risk
CHANNEL FOR LONG TAIL shops and the False Information
PRODUCTS
distributers
25
DC1 Business Model
26
Product Comparative
Factors PharmEasy DC1
Business & Product Mix PharmEasy earns by displaying -
the sponsored results of various
pharmaceutical entities.
Value-added services Order Medicine Order Medicine
Health care Products Health care Products
Lab Tests Lab Tests
Medicine Details Doctor consultations on chat
Easy and Hassel Free Return Medicine Details
Better Discount Offers
Geographical reach 22000 Pincode Served 600+ Cities
Revenue model Over all revenue : FY20 637 Cr. Over all revenue :FY20 541Cr.
Daily Orders : Approx. 12K Daily Orders : Approx. 8k
Average Order : 5L-6L per Yr Average Order : 3L per Yr
Shifts in the business Customer Acquisition The website was started as HealthKartPlus a platform
for users to have all the information about the
model medicines. The platform became so popular and got a
huge response from the public and users asked the
company to start the delivery of the medicines
27 too. Thus DC1 was started.
6.
COMPARE
STRENGTH &
WEEKNESS PharmEasy VS DC1
28
Strength and Weekness PharmEasy VS DC1
Factors PharmEasy DC1
Payment Has Good Payment Facility and options Need to improve in this function area
Order Confirmation Uploaded Perception gets confirm easily Uploaded Perception gets rejected as
per customer feed back
Delivery Time Quick easy and Fast Take time to deliver minimum 2 days
and maximum 15 days
User Interface Need to improve customer experience for Easy to understand and easy to use
better understanding.
29
Pain Points
DC1 PharmEasy
31
Particulars DC1 PharmEasy
App Downloads 10M+ 10M+
App Rating 3+ 3+
32
8.
Future Initiatives PharmEasy & DC1
33
Future initiatives
34
Thanks!
You can find me at
[email protected]
9375743866
35